blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2710015

EP2710015 - POLYMORPH OF RIFAXIMIN AND PROCESS FOR THE PREPARATION THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.03.2017
Database last updated on 24.04.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Clarochem Ireland Limited
Damastown, Mulhuddard
Dublin 15 / IE
[2014/13]
Inventor(s)01 / VIGANO', Enrico
Via S. Andrea 8
22040 Lurago d'Erba / IT
02 / MOLTENI, Renato
Via Maestri Comacini 12
22044 Inverigo / IT
03 / LANFRANCONI, Simona
Via Bellini 9
22070 Montano Lucino / IT
04 / ARRIGHI, Massimiliano
Via Michelangelo 6
22070 Luisago / IT
05 / GATTI, Fabio
Via Varesina 92
22075 Lurate Caccivio / IT
 [2014/13]
Representative(s)Cattaneo, Elisabetta, et al
Notarbartolo & Gervasi S.p.A.
Viale Achille Papa, 30
20149 Milano / IT
[N/P]
Former [2014/13]Cattaneo, Elisabetta, et al
Notarbartolo & Gervasi S.p.A Corso di Porta Vittoria, 9
20122 Milano / IT
Application number, filing date12731691.718.05.2012
[2016/20]
WO2012IB52506
Priority number, dateIT2011MI0089019.05.2011         Original published format: IT MI20110890
[2014/13]
Filing languageIT
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012156951
Date:22.11.2012
Language:EN
[2012/47]
Type: A1 Application with search report 
No.:EP2710015
Date:26.03.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 22.11.2012 takes the place of the publication of the European patent application.
[2014/13]
Type: B1 Patent specification 
No.:EP2710015
Date:18.05.2016
Language:EN
[2016/20]
Search report(s)International search report - published on:EP22.11.2012
ClassificationIPC:C07D498/22, A61K31/395, A61P1/00
[2014/13]
CPC:
C07D498/22 (EP,CN,KR,US); A61K31/439 (KR,US); A61K31/437 (KR);
A61P1/00 (EP); A61P1/04 (EP,KR); C07B2200/13 (KR)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/13]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:RIFAXIMIN-POLYMORPH UND VERFAHREN ZU SEINER HERSTELLUNG[2014/13]
English:POLYMORPH OF RIFAXIMIN AND PROCESS FOR THE PREPARATION THEREOF[2014/13]
French:POLYMORPHE DE LA RIFAXIMINE ET PROCÉDÉ POUR SA PRÉPARATION[2014/13]
Entry into regional phase18.12.2013National basic fee paid 
18.12.2013Designation fee(s) paid 
18.12.2013Examination fee paid 
Examination procedure08.11.2012Request for preliminary examination filed
International Preliminary Examining Authority: EP
18.12.2013Examination requested  [2014/13]
16.01.2015Despatch of a communication from the examining division (Time limit: M06)
22.07.2015Reply to a communication from the examining division
04.12.2015Communication of intention to grant the patent
31.03.2016Fee for grant paid
31.03.2016Fee for publishing/printing paid
31.03.2016Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.01.2015
Opposition(s)21.02.2017No opposition filed within time limit [2017/17]
Fees paidRenewal fee
22.04.2014Renewal fee patent year 03
12.05.2015Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU18.05.2012
AL18.05.2016
BG18.05.2016
CY18.05.2016
CZ18.05.2016
DK18.05.2016
EE18.05.2016
FI18.05.2016
HR18.05.2016
IS18.05.2016
LT18.05.2016
LU18.05.2016
MC18.05.2016
MK18.05.2016
RO18.05.2016
RS18.05.2016
SE18.05.2016
SK18.05.2016
SM18.05.2016
NO18.08.2016
GR19.08.2016
[2018/46]
Former [2018/38]HU18.05.2012
BG18.05.2016
CY18.05.2016
CZ18.05.2016
DK18.05.2016
EE18.05.2016
FI18.05.2016
HR18.05.2016
IS18.05.2016
LT18.05.2016
LU18.05.2016
MC18.05.2016
MK18.05.2016
RO18.05.2016
RS18.05.2016
SE18.05.2016
SK18.05.2016
SM18.05.2016
NO18.08.2016
GR19.08.2016
Former [2018/31]HU18.05.2012
CY18.05.2016
CZ18.05.2016
DK18.05.2016
EE18.05.2016
FI18.05.2016
HR18.05.2016
IS18.05.2016
LT18.05.2016
LU18.05.2016
MC18.05.2016
MK18.05.2016
RO18.05.2016
RS18.05.2016
SE18.05.2016
SK18.05.2016
SM18.05.2016
NO18.08.2016
GR19.08.2016
Former [2018/29]HU18.05.2012
CY18.05.2016
CZ18.05.2016
DK18.05.2016
EE18.05.2016
FI18.05.2016
HR18.05.2016
LT18.05.2016
LU18.05.2016
MC18.05.2016
MK18.05.2016
RO18.05.2016
RS18.05.2016
SE18.05.2016
SK18.05.2016
SM18.05.2016
NO18.08.2016
GR19.08.2016
Former [2018/28]HU18.05.2012
CY18.05.2016
CZ18.05.2016
DK18.05.2016
EE18.05.2016
FI18.05.2016
HR18.05.2016
LT18.05.2016
MC18.05.2016
MK18.05.2016
RO18.05.2016
RS18.05.2016
SE18.05.2016
SK18.05.2016
SM18.05.2016
NO18.08.2016
GR19.08.2016
Former [2017/22]CZ18.05.2016
DK18.05.2016
EE18.05.2016
FI18.05.2016
HR18.05.2016
LT18.05.2016
MC18.05.2016
RO18.05.2016
RS18.05.2016
SE18.05.2016
SK18.05.2016
SM18.05.2016
NO18.08.2016
GR19.08.2016
Former [2017/11]CZ18.05.2016
DK18.05.2016
EE18.05.2016
FI18.05.2016
HR18.05.2016
LT18.05.2016
RO18.05.2016
RS18.05.2016
SE18.05.2016
SK18.05.2016
SM18.05.2016
NO18.08.2016
GR19.08.2016
Former [2017/10]CZ18.05.2016
DK18.05.2016
EE18.05.2016
FI18.05.2016
HR18.05.2016
LT18.05.2016
RO18.05.2016
RS18.05.2016
SE18.05.2016
SK18.05.2016
NO18.08.2016
GR19.08.2016
Former [2017/09]CZ18.05.2016
DK18.05.2016
EE18.05.2016
FI18.05.2016
HR18.05.2016
LT18.05.2016
RO18.05.2016
RS18.05.2016
SE18.05.2016
NO18.08.2016
GR19.08.2016
Former [2017/07]DK18.05.2016
FI18.05.2016
HR18.05.2016
LT18.05.2016
RS18.05.2016
SE18.05.2016
NO18.08.2016
GR19.08.2016
Former [2016/52]FI18.05.2016
HR18.05.2016
LT18.05.2016
RS18.05.2016
SE18.05.2016
NO18.08.2016
GR19.08.2016
Former [2016/51]FI18.05.2016
HR18.05.2016
LT18.05.2016
RS18.05.2016
NO18.08.2016
GR19.08.2016
Former [2016/50]FI18.05.2016
HR18.05.2016
LT18.05.2016
RS18.05.2016
NO18.08.2016
Former [2016/49]FI18.05.2016
LT18.05.2016
NO18.08.2016
Former [2016/46]LT18.05.2016
NO18.08.2016
Cited inInternational search[I]US2005101598  (VISCOMI GIUSEPPE C [IT], et al) [I] 1-13 * figures 1-3; claims 1, 3, 5 *;
 [I]EP1698630  (ALFA WASSERMANN SPA [IT]) [I] 1-13 * figures 1,2; claims 1,2 *;
 [I]WO2009108730  (SALIX PHARMACEUTICALS LTD [US], et al) [I] 1-13 * claim 1 *;
 [I]US2010174064  (GUSHURST KAREN S [US], et al) [I] 1-13* claim 1 *
by applicantUS4341785
 EP1557421
 WO2006094662
 WO2009108730
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.